-
Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer’s disease: a systematic review
Oosthoek, M., Vermunt, L., de Wilde, A., Bongers, B., Antwi-Berko, D., Scheltens, P., van Bokhoven, P., Vijverberg, E. G. B. & Teunissen, C. E., 1 Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, 93.Research output: Contribution to journal › Article › Academic › peer-review
-
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer's disease
Das, S., van Engelen, M-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E. & Verberk, I. M. W., Dec 2024, In: Alzheimer's Research & Therapy. 16, 1, p. 34 34.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
